Viewing Study NCT04782284



Ignite Creation Date: 2024-05-06 @ 3:51 PM
Last Modification Date: 2024-10-26 @ 1:58 PM
Study NCT ID: NCT04782284
Status: RECRUITING
Last Update Posted: 2023-11-24
First Post: 2021-03-01

Brief Title: Comprehensive Swallowing Rehabilitation in Patients With MSA
Sponsor: Seoul National University Hospital
Organization: Seoul National University Hospital

Study Overview

Official Title: Effect of Comprehensive Swallowing Rehabilitation in Patients With Multiple System Atrophy A Randomized Controlled Trial
Status: RECRUITING
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to investigate the effect of comprehensive swallowing rehabilitation in patients with multiple system atrophy
Detailed Description: Multiple system atrophy MSA is a rapidly progressive neurodegenerative disease characterized by parkinsonism cerebellar syndrome and autonomic failure Dysphagia is a clinically significant symptom leading to pneumonia that causes death in patients with MSA Although the symptoms of dysphagia in the two subtypes of MSA-the parkinsonian variant and the cerebellar variant- are different there is no significant difference in the latency to onset of tube feeding Therefore effective intervention is needed to improve the safety and efficiency of swallowing regardless of the subtypes of MSA

Although swallowing rehabilitation has been widely applied for swallowing disorders in patients with MSA few studies have reported the clinical effect of applying swallowing therapy Comprehensive swallowing rehabilitation has focused on functional muscle training compensatory swallowing maneuvers and thermal-tactile stimulation which is used to treat dysphagia from stroke Parkinsons disease and head and neck cancer Therefore this study aims to investigate the effect of comprehensive swallowing rehabilitation in patients with MSA

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None